Costs and savings associated with a pharmacists prescribing for minor ailments program in Saskatchewan

Table 3 Costs of the PPMA program and the alternative from the public payer and societal perspectives in 2014 and in the next 5 years

	Public payer perspective	Societal perspective	Public payer perspective	Societal perspective
	2014		2015–2019
PPMA program
Investment cost of PPMA^a	$193,302	$254,514	$1,110,134	$1,375,154
Running cost of PPMA	$149,162	$401,432	$856,641	$2,305,430
Alternative scenario
Cost of alternative	$350,715	$1,202,780	$2,014,161	$7,163,244
Benefits of PPMA
Benefit (cost-saving)^b	$201,552	$801,347	$1,157,519	$4,857,814
Net cost–saving^c	$8,250	$546,832	$47,385	$3,482,660
Cost–saving per consultation^d	$0.77	$50.92	$0.66	$48.73
ROI^e	0.04	2.15	0.04	2.53

^aInvestment cost of PPMA = (Total number of consultation* fee) under public payer perspective
Investment cost of PPMA = (Total number of consultation* fee) + annual training cost under societal perspective
^bBenefit (cost-saving) = (Cost of alternative − cost of PPMA)
^cNet cost-Saving = (Cost-saving − investment cost of PPMA)
^dNet cost–saving per consultation: (Net cost saving/total number of consultation)
^eROI net cost–saving/investment cost of PPMA

ISSN: 1478-7547